Elara MD review

What it is

Elara MD is a weight-loss and wellness telehealth platform offering sermorelin as an injection or a troche, glutathione injections and NAD⁺ injections, alongside weekly injectable GLP-1 plans marketed as "Personalized GLP-1" and "GLP-1/GIP + B12" with microdosing options. It says it serves patients in over 40 states, and its Terms of Use are governed by the law of the State of Georgia. It is a distinct company from Elara Health and Wellness, which operates a different domain, pricing and service menu.

How it works

A standard direct-to-consumer telehealth flow, with a monthly plan that includes a 30-day supply shipped every 30 days and free shipping in one to four days when prescribed. Medication included in the monthly price is a clean structure and easy to compare against providers that bill medication separately. The disclosure picture around it is the problem, and it is not one gap but a cluster. The Terms refer to "Elara MD and/or our owners and/or affiliates" without naming a registered entity, so there is no company to look up. No medical director or clinical lead is named. No LegitScript or other third-party certification is disclosed. No state list backs the "over 40 states" claim. And on pharmacy, the Terms state that while there may be a preferred pharmacy used, the patient can direct their prescription to any pharmacy of their choosing — which sounds like flexibility, and in practice means no partner pharmacy is named or standing behind the compounding. The site has also at times sat behind aggressive anti-bot gating, which is a legitimate security measure but adds friction to verifying anything independently.

Pricing transparency

Unusually detailed on one side and silent on the other. The GLP-1 tables publish a band-by-band schedule: the semaglutide-range "Personalized GLP-1" plan at $249 a month for the 0.2 and 0.4 mg weekly bands and $349 from 0.9 mg upward, and the tirzepatide-range "GLP-1/GIP + B12" plan stepping from $349 at 2.0 and 4.0 mg through $449 and $549 to $649 at the top bands. That granularity is genuinely useful — it lets you see what a maintenance dose costs before you start, which most competitors will not show. It also tells you this pricing scales with dose rather than staying flat, so budget for the band you expect to reach, not the one you start on. For sermorelin, glutathione and NAD⁺, no price is published at all and we are not quoting one; the GLP-1 figures are weight-loss prices and are not transferable. Ask for the peptide monthly price, what dose and route it supplies, and whether it too steps up with dose.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate — and here that statement is ours rather than the provider's, because Elara MD does not publish a compounded-medication disclaimer on its site at all, and does not explicitly name the molecules in its GLP-1 plans, describing them only as "Personalized GLP-1" and "GLP-1/GIP + B12". The compounded status is inferred from the dose bands and pricing rather than stated, which is a genuine gap in a category where the FDA-approval distinction is the single most important thing a buyer needs to understand. No compounding pharmacy stands behind the products: the Terms put the choice of pharmacy on the patient. On the evidence, the wellness line splits three ways. Sermorelin, in injection or troche form, acts on the growth-hormone axis — a real mechanism with thin long-term human outcome data and no controlled trial behind the body-composition claims; the troche route in particular has no comparative bioavailability data published here. Injectable glutathione has essentially no controlled human outcome evidence. Injected NAD⁺ has no controlled outcome trials either; the oral precursors NR and NMN are the studied forms and they raise blood NAD⁺, a biomarker rather than a clinical outcome. Individual results vary.

Pros and watch-outs

The evidence behind what Elara MD prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

How Elara MD compares

A few alternatives worth a look, depending on what you’re optimizing for.

• SLSystem Labs

  NAD⁺ bundled with glutathione, B-12 and sermorelin from one service

  See System Labs →
• Telos RX

  Choice of GLP-1 formats, including needle-free sublingual tirzepatide

  See Telos RX →
• LHLuvo Health

  Prescription NAD⁺ as an injection, drops or nasal spray at one flat price

  See Luvo Health →